| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
4e-05 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
0.0004 |
| mRNA |
BRD-K84807411 |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
0.0007 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.001 |
| mRNA |
JQ-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
| mRNA |
SB52334 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |